Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Pfizer to advance once-daily formulation of oral GLP-1 receptor agonist danuglipron

The drugmaker said last year that it would be dropping its twice-daily formulation of the candidate

- PMLiVE

Lexeo’s gene therapy candidate shows promise in Friedreich’s ataxia cardiomyopathy

The neurodegenerative movement disorder affects approximately one in every 40,000 people

- PMLiVE

ICR study reveals Lynparza could treat more advanced prostate cancer patients

Up to 30% of men living with the advanced disease have tumours that contain defects in repairing DNA

- PMLiVE

Researchers identify free light chain targets to help treat rare form of amyloidosis

AL amyloidosis is currently the most common and severe form of the condition

Doctor speaking to patient and clinical setting in Cuttsy+Cuttsy branded shapes

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Cuttsy + Cuttsy

- PMLiVE

Roche’s subcutaneous Ocrevus granted MHRA approval to treat relapsing and primary MS

The NHS said it expects stock of the ten-minute injection to be available in the coming weeks

- PMLiVE

Novo Nordisk’s Ozempic associated with cognitive benefits in diabetes patients

Researchers from the University of Oxford analysed records from more than 100 million patients in the US

- PMLiVE

Immutep’s LAG-3 immunotherapy candidate shows promise in head and neck cancer

Approximately 600,000 new cases of head and neck squamous cell carcinoma are diagnosed globally every year

- PMLiVE

Phesi publishes new analysis revealing top five most studied diseases globally

The analysis also showed that 32% of phase 2 trials were terminated in the first half of 2024

- PMLiVE

Chiesi’s rare disorder therapies approved by SMC for Fabry disease and epidermolysis bullosa

Rare diseases currently affect around 436,000 people living in Scotland

- PMLiVE

uniQure’s investigational gene therapy shown to slow Huntington’s disease progression

The neurodegenerative disorder affects approximately 70,000 people in Europe and the US

- PMLiVE

Francis Crick Institute appoints Edith Heard as new director and chief executive

The current director-general of the European Molecular Biology Laboratory will take on the role next year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links